{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:29:54Z","timestamp":1791944994252,"version":"4.3.4"},"reference-count":268,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    Tauopathies are both clinical and pathological heterogeneous disorders characterized by neuronal and\/or glial accumulation of misfolded tau protein. It is now well understood that every pathologic tauopathy may present with various clinical phenotypes based on the primary site of involvement and the spread and distribution of the pathology in the nervous system making clinicopathological correlation more and more challenging. The clinical spectrum of tauopathies includes syndromes with a strong association with an underlying primary tauopathy, including Richardson syndrome (RS), corticobasal syndrome (CBS), non-fluent agrammatic primary progressive aphasia (nfaPPA)\/apraxia of speech, pure akinesia with gait freezing (PAGF), and behavioral variant frontotemporal dementia (bvFTD), or weak association with an underlying primary tauopathy, including Parkinsonian syndrome, late-onset cerebellar ataxia, primary lateral sclerosis, semantic variant PPA (svPPA), and amnestic syndrome. Here, we discuss clinical syndromes associated with various primary tauopathies and their distinguishing clinical features and new biomarkers becoming available to improve\n                    <jats:italic>in vivo<\/jats:italic>\n                    diagnosis. Although the typical phenotypic clinical presentations lead us to suspect specific underlying pathologies, it is still challenging to differentiate pathology accurately based on clinical findings due to large phenotypic overlaps. Larger pathology-confirmed studies to validate the use of different biomarkers and prospective longitudinal cohorts evaluating detailed clinical, biofluid, and imaging protocols in subjects presenting with heterogenous phenotypes reflecting a variety of suspected underlying pathologies are fundamental for a better understanding of the clinicopathological correlations.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2022.944806","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:59:34Z","timestamp":1657760374000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Clinical Spectrum of Tauopathies"],"prefix":"10.3389","volume":"13","author":[{"given":"Nahid","family":"Olfati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shoeibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Litvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A Protein Factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B2","unstructured":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary ninds neuropathologic criteria for Steele-Richardson-Olszewski Syndrome (Progressive Supranuclear Palsy)","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/neup.12143","article-title":"Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration","volume":"34","author":"Yoshida","year":"2014","journal-title":"Neuropathology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"office of rare diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"Dickson","year":"2002","journal-title":"J Neuropathol Exp Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00401-013-1171-0","article-title":"Globular Glial Tauopathies (Ggt): consensus recommendations","volume":"126","author":"Ahmed","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/nan.12581","article-title":"Morphological characterisation of glial and neuronal tau pathology in globular glial tauopathy (Types II and III)","volume":"46","author":"Tanaka","year":"2020","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jnen\/63.9.911","article-title":"Staging of argyrophilic grains: an age-associated tauopathy","volume":"63","author":"Saito","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0304-3940(87)90204-7","article-title":"Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without alzheimer changes","volume":"76","author":"Braak","year":"1987","journal-title":"Neurosci Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","article-title":"Aging-Related Tau Astrogliopathy (Artag): harmonized evaluation strategy","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5414\/NP301264","article-title":"Aging-related tau astrogliopathy: a brief review","volume":"39","author":"Das","year":"2020","journal-title":"Clin Neuropathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s004010050565","article-title":"Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment","volume":"92","author":"Probst","year":"1996","journal-title":"Acta Neuropathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1212\/WNL.56.suppl_4.S16","article-title":"Neuropathology of Pick's disease","volume":"56","author":"Dickson","year":"2001","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","article-title":"Primary age-related tauopathy (Part): A common pathology associated with human aging","volume":"128","author":"Crary","year":"2014","journal-title":"Acta Neuropathol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41586-021-03911-7","article-title":"Structure-based classification of tauopathies","volume":"598","author":"Shi","year":"2021","journal-title":"Nature."},{"key":"B17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","article-title":"Tau in neurodegenerative disease","volume":"6","author":"Gao","year":"2018","journal-title":"Ann Transl Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"754669","DOI":"10.3389\/fneur.2021.754669","article-title":"Editorial: tau pathology in neurological disorders","volume":"12","author":"Do Carmo","year":"2021","journal-title":"Front Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"102152","DOI":"10.1016\/j.nicl.2019.102152","article-title":"Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants","volume":"25","author":"Whitwell","year":"2020","journal-title":"Neuroimage Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"117293","DOI":"10.1016\/j.jns.2020.117293","article-title":"Disease course and treatment patterns in progressive supranuclear Palsy: a real-world study","volume":"421","author":"Morgan","year":"2021","journal-title":"J Neurol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's Syndrome and Psp-Parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain."},{"key":"B23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mds.27872","article-title":"Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies","volume":"35","author":"Respondek","year":"2020","journal-title":"Mov Disord."},{"key":"B24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the Diagnosis of Corticobasal Degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1590\/s1980-5764-2016dn1004003","article-title":"Corticobasal syndrome: a diagnostic conundrum","volume":"10","author":"Parmera","year":"2016","journal-title":"Dement Neuropsychol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1212\/WNL.0b013e318202038c","article-title":"Tdp-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia","volume":"75","author":"Rohrer","year":"2010","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ana.24885","article-title":"Typical and atypical pathology in primary progressive aphasia variants","volume":"81","author":"Spinelli","year":"2017","journal-title":"Ann Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00002093-199205000-00004","article-title":"Clinically diagnosed alzheimer disease: neuropathologic findings in 650 cases alzheimer","volume":"6","author":"Mendez","year":"1992","journal-title":"Dis Assoc Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neurobiolaging.2020.07.011","article-title":"Does amnesia specifically predict alzheimer's pathology? A neuropathological study","volume":"95","author":"Bertoux","year":"2020","journal-title":"Neurobiol Aging."},{"key":"B30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/jnen\/nlaa014","article-title":"Concordance of clinical alzheimer diagnosis and neuropathological features at autopsy","volume":"79","author":"Gauthreaux","year":"2020","journal-title":"J Neuropathol Exp Neurol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1176\/ajp.147.2.168","article-title":"Neuropathological findings in patients with clinical diagnoses of probable alzheimer's disease","volume":"147","author":"Risse","year":"1990","journal-title":"Am J Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1007\/s00415-020-09927-9","article-title":"Pick's disease: clinicopathologic characterization of 21 cases","volume":"267","author":"Choudhury","year":"2020","journal-title":"J Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.parkreldis.2021.07.007","article-title":"Clinical features of autopsy-confirmed multiple system atrophy in the mayo clinic Florida Brain Bank","volume":"89","author":"Koga","year":"2021","journal-title":"Parkinsonism Relat Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jamaneurol.2021.1813","article-title":"Association between globular glial tauopathies and frontotemporal dementia-expanding the spectrum of gliocentric disorders: a review","volume":"78","author":"Forrest","year":"2021","journal-title":"JAMA Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia","volume":"140","author":"Perry","year":"2017","journal-title":"Brain."},{"key":"B36","first-page":"2565","article-title":"Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration","volume-title":"Brain.","author":"Rohrer","year":"2011"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant Age-Related Tdp-43 Encephalopathy (Late): Consensus Working Group Report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain."},{"key":"B38","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/jnen\/nlw034","article-title":"Argyrophilic grain disease: demographics, clinical, and neuropathological features from a large autopsy study","volume":"75","author":"Rodriguez","year":"2016","journal-title":"J Neuropathol Exp Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11910-020-01063-1","article-title":"Primary Age-Related Tauopathy (Part): addressing the spectrum of neuronal tauopathic changes in the aging brain","volume":"20","author":"Hickman","year":"2020","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/brain\/awz403","article-title":"Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy","volume":"143","author":"Teylan","year":"2020","journal-title":"Brain."},{"key":"B41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/13554794.2020.1732427","article-title":"Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity","volume":"26","author":"Liu","year":"2020","journal-title":"Neurocase."},{"key":"B43","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.parkreldis.2016.12.009","article-title":"Understanding falls in progressive supranuclear palsy","volume":"35","author":"Bluett","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/BF02336701","article-title":"Progressive supranuclear palsy 1979: an overview","volume":"1","author":"Brusa","year":"1980","journal-title":"Ital J Neurol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome): report of the Ninds-Spsp International Workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology."},{"key":"B46","first-page":"1438","article-title":"The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome) in the Uk","volume-title":"Brain.","author":"Nath","year":"2001"},{"key":"B47","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0072-9752(07)01242-0","article-title":"The epidemiology of progressive supranuclear palsy","volume":"89","author":"Golbe","year":"2008","journal-title":"Handb Clin Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2018.03.030","article-title":"Descriptive Epidemiology of Parkinsonism in the Canton of Geneva, Switzerland","volume":"54","author":"Fleury","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3233\/JPD-191744","article-title":"Incidence and trends of progressive supranuclear palsy and corticobasal syndrome: a population-based study","volume":"10","author":"Stang","year":"2020","journal-title":"J Parkinsons Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1212\/WNL.38.7.1031","article-title":"Prevalence and natural history of progressive supranuclear palsy","volume":"38","author":"Golbe","year":"1988","journal-title":"Neurology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40035-019-0160-1","article-title":"How to spot ocular abnormalities in progressive supranuclear palsy? A practical review transl","volume":"8","author":"Phokaewvarangkul","year":"2019","journal-title":"Neurodegener."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/jnnp.2003.027367","article-title":"Abnormalities of Optokinetic Nystagmus in progressive supranuclear palsy","volume":"75","author":"Garbutt","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.clinph.2012.07.008","article-title":"Deterioration of horizontal saccades in progressive supranuclear palsy","volume":"124","author":"Terao","year":"2013","journal-title":"Clin Neurophysiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1212\/WNL.44.4.716","article-title":"Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study","volume":"44","author":"Malessa","year":"1994","journal-title":"Neurology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410020509","article-title":"The ocular motor defects in progressive supranuclear palsy","volume":"2","author":"Troost","year":"1977","journal-title":"Ann Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1212\/WNL.54.5.1029","article-title":"Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy","volume":"54","author":"Rivaud-Pechoux","year":"2000","journal-title":"Neurology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"674495","DOI":"10.3389\/fneur.2021.674495","article-title":"Gait analysis in progressive supranuclear palsy phenotypes","volume":"12","author":"Picillo","year":"2021","journal-title":"Front Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1600-0404.1998.tb01723.x","article-title":"Progressive supranuclear palsy revisited","volume":"98","author":"Litvan","year":"1998","journal-title":"Acta Neurol Scand."},{"key":"B59","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.parkreldis.2015.05.017","article-title":"Discriminating features of gait performance in progressive supranuclear palsy","volume":"21","author":"Amano","year":"2015","journal-title":"Parkinsonism Relat Disord."},{"key":"B60","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2377-12-116","article-title":"Comparison of gait in progressive supranuclear palsy, parkinson's disease and healthy older adults","volume":"12","author":"Egerton","year":"2012","journal-title":"BMC Neurol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2020.07.009","article-title":"Understanding the relationship between freezing of gait and other progressive supranuclear palsy features","volume":"78","author":"Rezvanian","year":"2020","journal-title":"Parkinsonism Relat Disord."},{"key":"B62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.parkreldis.2016.03.015","article-title":"Tremor in progressive supranuclear palsy","volume":"27","author":"Fujioka","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B63","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/jnnp.60.6.615","article-title":"Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome) and clinical predictors of survival: a clinicopathological study","volume":"60","author":"Litvan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B64","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00415-015-7671-1","article-title":"Speech disorders reflect differing pathophysiology in parkinson's disease, progressive supranuclear palsy and multiple system atrophy","volume":"262","author":"Rusz","year":"2015","journal-title":"J Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1044\/2020_AJSLP-20-00126","article-title":"Motor speech disorders and communication limitations in progressive supranuclear palsy","volume":"30","author":"Clark","year":"2021","journal-title":"Am J Speech Lang Pathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1212\/01.WNL.0000052686.97625.27","article-title":"Progression of gait, speech and swallowing deficits in progressive supranuclear palsy","volume":"60","author":"Goetz","year":"2003","journal-title":"Neurology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1212\/WNL.48.6.1654","article-title":"Characterizing swallowing abnormalities in progressive supranuclear palsy","volume":"48","author":"Litvan","year":"1997","journal-title":"Neurology."},{"key":"B68","first-page":"980","article-title":"Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients","volume-title":"Parkinsonism Relat Disord.","author":"dell'Aquila","year":"2013"},{"key":"B69","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000479110","article-title":"Mild cognitive impairment and progression to dementia in progressive supranuclear palsy","volume":"17","author":"Pilotto","year":"2017","journal-title":"Neurodegener Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/jnnp.37.2.121","article-title":"The 'Subcortical Dementia' of progressive supranuclear palsy","volume":"37","author":"Albert","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-7091-6641-3_6","article-title":"Cognitive disturbances in progressive supranuclear palsy","volume":"42","author":"Litvan","year":"1994","journal-title":"J Neural Transm Suppl."},{"key":"B72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/arclin\/acs098","article-title":"Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy","volume":"28","author":"Gerstenecker","year":"2013","journal-title":"Arch Clin Neuropsychol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"107772","DOI":"10.1016\/j.neuropsychologia.2021.107772","article-title":"Phonemic fluency quantity and quality: comparing patients with psp, parkinson's disease and focal frontal and subcortical lesions","volume":"153","author":"Foley","year":"2021","journal-title":"Neuropsychologia."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3233\/JAD-210023","article-title":"Phonemic verbal fluency and midbrain atrophy in progressive supranuclear palsy","volume":"80","author":"Luca","year":"2021","journal-title":"J Alzheimers Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2017.10.002","article-title":"Neuropsychiatric and cognitive profile of early richardson's syndrome, progressive supranuclear palsy-parkinsonism and parkinson's disease","volume":"45","author":"Pellicano","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s00415-021-10511-y","article-title":"Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes","volume":"268","author":"Horta-Barba","year":"2021","journal-title":"J Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/brain\/awl367","article-title":"Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy","volume":"130","author":"O'Keeffe","year":"2007","journal-title":"Brain."},{"key":"B78","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00415-015-7657-z","article-title":"Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia","volume":"262","author":"Kobylecki","year":"2015","journal-title":"J Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/brain\/aws128","article-title":"Social cognitive deficits and their neural correlates in progressive supranuclear palsy","volume":"135","author":"Ghosh","year":"2012","journal-title":"Brain."},{"key":"B80","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/jnnp.65.5.717","article-title":"Neuropsychiatric features of corticobasal degeneration","volume":"65","author":"Litvan","year":"1998","journal-title":"J Neurol, Neurosurg Psych."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.psychres.2013.08.045","article-title":"Behavioral abnormalities in progressive supranuclear palsy","volume":"210","author":"Gerstenecker","year":"2013","journal-title":"Psychiatry Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1017\/S135561770909050X","article-title":"Rule violation errors are associated with right lateral prefrontal cortex atrophy in neurodegenerative disease","volume":"15","author":"Possin","year":"2009","journal-title":"J Int Neuropsychol Soc."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.2147\/NDT.S178263","article-title":"Neuropsychiatric disturbances in atypical parkinsonian disorders","volume":"14","author":"Belvisi","year":"2018","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/archneur.55.8.1099","article-title":"Pharmacological therapy in progressive supranuclear palsy","volume":"55","author":"Kompoliti","year":"1998","journal-title":"Arch Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1176\/jnp.13.1.42","article-title":"Neuropsychiatric symptoms of patients with progressive supranuclear palsy and parkinson's disease","volume":"13","author":"Aarsland","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ana.410190405","article-title":"Human autonomy and the frontal lobes. part II: patient behavior in complex and social situations: the \u201cEnvironmental Dependency Syndrome.\u201d Ann Neurol","volume":"19","author":"Lhermitte","year":"1986"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1007\/s00415-013-6976-1","article-title":"The clinical and anatomical heterogeneity of environmental dependency phenomena","volume":"260","author":"Lagarde","year":"2013","journal-title":"J Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0022-510X(95)00015-T","article-title":"Environment-driven responses in progressive supranuclear palsy","volume":"130","author":"Ghika","year":"1995","journal-title":"J Neurol Sci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1212\/WNL.46.4.922","article-title":"Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome)","volume":"46","author":"Litvan","year":"1996","journal-title":"Neurology."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/mds.27619","article-title":"Sensitivity and specificity of diagnostic criteria for progressive supranuclear palsy","volume":"34","author":"Ali","year":"2019","journal-title":"Movement Disorders."},{"key":"B91","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"Hoglinger","year":"2017","journal-title":"Mov Disord."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology."},{"key":"B93","first-page":"2456","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume-title":"Brain.","author":"Rascovsky","year":"2011"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.27408","article-title":"Mds Psp criteria in real-life clinical setting: motor and cognitive characterization of subtypes","volume":"33","author":"Picillo","year":"2018","journal-title":"Movement Disorders."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/mds.27666","article-title":"How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy","volume":"34","author":"Grimm","year":"2019","journal-title":"Mov Disord."},{"key":"B96","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.parkreldis.2020.06.030","article-title":"Video-tutorial for the movement disorder society criteria for progressive supranuclear palsy","volume":"78","author":"Iankova","year":"2020","journal-title":"Parkinsonism Relat Disord."},{"key":"B97","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/mdc3.12894","article-title":"Graphic summary of movement disorders society criteria for progressive supranuclear palsy and multiple allocations extinction rules","volume":"7","author":"Ogawa","year":"2020","journal-title":"Mov Disord Clin Pract."},{"key":"B98","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/brainsci11060695","article-title":"Of criteria and men-diagnosing atypical parkinsonism: towards an algorithmic approach","volume":"11","author":"Cozma","year":"2021","journal-title":"Brain Sci."},{"key":"B99","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.10.012","article-title":"Are the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy (Ipmds-Psp) diagnostic criteria accurate enough to differentiate common psp phenotypes?","volume-title":"Parkinsonism Relat Disord.","author":"Shoeibi","year":"2019"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1002\/acn3.51065","article-title":"Mds Criteria for the diagnosis of progressive supranuclear palsy overemphasize richardson syndrome","volume":"7","author":"Frank","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mds.28822","article-title":"Autopsy validation of progressive supranuclear palsy-predominant speech\/language disorder criteria","volume":"37","author":"Hokelekli","year":"2022","journal-title":"Mov Disord."},{"key":"B102","doi-asserted-by":"publisher","first-page":"827338","DOI":"10.3389\/fneur.2022.827338","article-title":"Is the phenotype designation by Psp-Mds criteria stable throughout the disease course and consistent with tau distribution?","volume":"13","author":"Sanchez-Ruiz","year":"2022","journal-title":"Front Neurol."},{"key":"B103","article-title":"Utility of the movement disorders society criteria for progressive supranuclear palsy in clinical practice: clinical utility of Psp criteria","volume-title":"Mov Disord Clin Pract.","author":"Ali","year":"2019"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1093\/brain\/awr234","article-title":"Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or richardson syndrome","volume":"134","author":"Kouri","year":"2011","journal-title":"Brain."},{"key":"B105","first-page":"II1","article-title":"clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration","volume-title":"J Neurol.","author":"Litvan","year":"1999"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","article-title":"Does corticobasal degeneration exist? A clinicopathological re-evaluation","volume":"133","author":"Ling","year":"2010","journal-title":"Brain."},{"key":"B107","first-page":"23","article-title":"Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life","volume":"92","author":"Rebeiz","year":"1967","journal-title":"Trans Am Neurol Assoc."},{"key":"B108","first-page":"1171","article-title":"Corticobasal degeneration","volume-title":"Brain.","author":"Gibb","year":"1989"},{"key":"B109","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.prdoa.2019.08.005","article-title":"Corticobasal degeneration and corticobasal syndrome: a review","volume":"1","author":"Constantinides","year":"2019","journal-title":"Clin Park Relat Disord."},{"key":"B110","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.parkreldis.2009.11.013","article-title":"Symmetric corticobasal degeneration (S-Cbd)","volume":"16","author":"Hassan","year":"2010","journal-title":"Parkinsonism Relat Disord."},{"key":"B111","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/mds.870100203","article-title":"Unique myoclonic pattern in corticobasal degeneration","volume":"10","author":"Brunt","year":"1995","journal-title":"Mov Disord."},{"key":"B112","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/mds.870130126","article-title":"Electrophysiological studies of early stage corticobasal degeneration","volume":"13","author":"Lu","year":"1998","journal-title":"Mov Disord."},{"key":"B113","first-page":"75","article-title":"Apraxia in parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism","volume-title":"Brain.","author":"Leiguarda","year":"1997"},{"key":"B114","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1212\/WNL.56.7.957","article-title":"Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy","volume":"56","author":"Pharr","year":"2001","journal-title":"Neurology."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00415-019-09672-8","article-title":"Alien limb in the corticobasal syndrome: phenomenological characteristics and relationship to apraxia","volume":"267","author":"Lewis-Smith","year":"2020","journal-title":"J Neurol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/jnnp.68.1.83","article-title":"Subjective experience, involuntary movement, and posterior alien hand syndrome","volume":"68","author":"Bundick","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B117","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10072-003-0149-4","article-title":"The alien hand syndrome: classification of forms reported and discussion of a new condition","volume":"24","author":"Aboitiz","year":"2003","journal-title":"Neurol Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.parkreldis.2012.07.010","article-title":"Characterising the uncommon corticobasal syndrome presentation of sporadic creutzfeldt-jakob disease","volume":"19","author":"Lee","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1212\/WNL.0000000000005828","article-title":"Diffuse lewy body disease manifesting as corticobasal syndrome: a rare form of lewy body disease","volume":"91","author":"Kasanuki","year":"2018","journal-title":"Neurology."},{"key":"B120","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2019.09.001","article-title":"Cerebrovascular pathology presenting as corticobasal syndrome: an autopsy case series of \u201cVascular Cbs\u201d","volume":"68","author":"Koga","year":"2019","journal-title":"Parkinsonism Relat Disord."},{"key":"B121","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/13554794.2021.1921220","article-title":"An autopsy case of corticobasal syndrome with pure diffuse lewy body disease","volume":"27","author":"Ichinose","year":"2021","journal-title":"Neurocase."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/01.wnl.0000259519.78480.c3","article-title":"Cognitive and motor assessment in autopsy-proven corticobasal degeneration","volume":"68","author":"Murray","year":"2007","journal-title":"Neurology."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/mds.22574","article-title":"Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome","volume":"24","author":"Hu","year":"2009","journal-title":"Mov Disord."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/mds.22558","article-title":"Is the Pathology of corticobasal syndrome predictable in life?","volume":"24","author":"Shelley","year":"2009","journal-title":"Mov Disord."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1586\/ern.11.153","article-title":"The corticobasal syndrome-alzheimer's disease conundrum","volume":"11","author":"Hassan","year":"2011","journal-title":"Expert Rev Neurother."},{"key":"B126","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/13554794.2018.1494290","article-title":"Early stage memory impairment, visual hallucinations, and myoclonus combined with temporal lobe atrophy predict alzheimer's disease pathology in corticobasal syndrome","volume":"24","author":"Jung","year":"2018","journal-title":"Neurocase."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.jalz.2019.04.011","article-title":"Clinicopathologic subtype of alzheimer's disease presenting as corticobasal syndrome","volume":"15","author":"Sakae","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B129","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1212\/WNL.0000000000000667","article-title":"Visuoperception test predicts pathologic diagnosis of alzheimer disease in corticobasal syndrome","volume":"83","author":"Boyd","year":"2014","journal-title":"Neurology."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2353\/ajpath.2006.060438","article-title":"Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies","volume":"169","author":"Sampathu","year":"2006","journal-title":"Am J Pathol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A harmonized classification system for Ftld-Tdp pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/jnnp-2020-322983","article-title":"Tdp-43 proteinopathies: a new wave of neurodegenerative diseases","volume":"92","author":"de Boer","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B133","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-009-0605-1","article-title":"Sporadic corticobasal syndrome due to Ftld-Tdp","volume":"119","author":"Tartaglia","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12031-011-9626-z","article-title":"Symmetrical corticobasal syndrome caused by a novel C314dup progranulin mutation","volume":"45","author":"Dopper","year":"2011","journal-title":"J Mol Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/jnnp-2013-307035","article-title":"Validation of the new consensus criteria for the diagnosis of corticobasal degeneration","volume":"85","author":"Alexander","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B136","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mds.25746","article-title":"Pathology and sensitivity of current clinical criteria in corticobasal syndrome","volume":"29","author":"Ouchi","year":"2014","journal-title":"Mov Disord."},{"key":"B137","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cortex.2021.09.005","article-title":"Primary progressive aphasias associated with C9orf72 expansions: another side of the story","volume":"145","author":"Saracino","year":"2021","journal-title":"Cortex."},{"key":"B138","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/brain\/awv358","article-title":"Clinical features of Tbk1 carriers compared with C9orf72, Grn and non-mutation carriers in a Belgian Cohort","volume":"139","author":"Van Mossevelde","year":"2016","journal-title":"Brain."},{"key":"B139","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/02687038.2014.911242","article-title":"The genetics of primary progressive aphasia","volume":"28","author":"Rohrer","year":"2014","journal-title":"Aphasiology."},{"key":"B140","doi-asserted-by":"publisher","first-page":"e2355","DOI":"10.1212\/WNL.0000000000007498","article-title":"Incidence of frontotemporal lobar degeneration in Italy: the Salento-Brescia registry study","volume":"92","author":"Logroscino","year":"2019","journal-title":"Neurology."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1212\/01.wnl.0000436070.28137.7b","article-title":"Classification and pathology of primary progressive aphasia","volume":"81","author":"Harris","year":"2013","journal-title":"Neurology."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1212\/WNL.0000000000000261","article-title":"Quantitative application of the primary progressive aphasia consensus criteria","volume":"82","author":"Wicklund","year":"2014","journal-title":"Neurology."},{"key":"B143","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/02687038.2020.1787732","article-title":"Primary progressive apraxia of speech: from recognition to diagnosis and care","volume":"35","author":"Duffy","year":"2021","journal-title":"Aphasiology."},{"key":"B144","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1474-4422(12)70099-6","article-title":"The non-fluent\/agrammatic variant of primary progressive aphasia","volume":"11","author":"Grossman","year":"2012","journal-title":"Lancet Neurol."},{"key":"B145","volume-title":"Motor Speech Disorders : Substrates, Differential Diagnosis, and Management","author":"Duffy","year":"2020"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s00415-018-8762-6","article-title":"Primary progressive aphasia: a clinical approach","volume":"265","author":"Marshall","year":"2018","journal-title":"J Neurol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-3-030-51140-1_3","article-title":"Nosology of primary progressive aphasia and the neuropathology of language","volume":"1281","author":"Mesulam","year":"2021","journal-title":"Adv Exp Med Biol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1212\/WNL.0000000000000031","article-title":"In vivo signatures of nonfluent\/agrammatic primary progressive aphasia caused by Ftld pathology","volume":"82","author":"Caso","year":"2014","journal-title":"Neurology."},{"key":"B149","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/jamaneurol.2016.0412","article-title":"Features of patients with nonfluent\/agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration","volume":"73","author":"Santos-Santos","year":"2016","journal-title":"JAMA Neurol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1212\/CPJ.0000000000000919","article-title":"Survival analysis in primary progressive apraxia of speech and agrammatic aphasia","volume":"11","author":"Whitwell","year":"2021","journal-title":"Neurol Clin Pract."},{"key":"B151","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jamaneurol.2021.4417","article-title":"Research criteria for the behavioral variant of alzheimer disease: a systematic review and meta-analysis","volume":"79","author":"Ossenkoppele","year":"2022","journal-title":"JAMA Neurol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of alzheimer's disease: clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain."},{"key":"B153","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/psyg.12334","article-title":"Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration","volume":"18","author":"Kobayashi","year":"2018","journal-title":"Psychogeriatrics."},{"key":"B154","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1212\/WNL.0b013e3182815547","article-title":"Clinicopathologic differences among patients with behavioral variant frontotemporal dementia","volume":"80","author":"Mendez","year":"2013","journal-title":"Neurology."},{"key":"B155","doi-asserted-by":"publisher","first-page":"fcab206","DOI":"10.1093\/braincomms\/fcab206","article-title":"Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants","volume":"3","author":"Street","year":"2021","journal-title":"Brain Commun."},{"key":"B156","doi-asserted-by":"publisher","first-page":"729381","DOI":"10.3389\/fneur.2021.729381","article-title":"The psychiatric misdiagnosis of behavioral variant frontotemporal dementia in a Colombian sample","volume":"12","author":"Zapata-Restrepo","year":"2021","journal-title":"Front Neurol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","article-title":"Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an International Retrospective Cohort Study","volume":"19","author":"Moore","year":"2020","journal-title":"The Lancet Neurology."},{"key":"B158","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-3-030-51140-1_6","article-title":"Clinical and neuroimaging aspects of familial frontotemporal lobar degeneration associated with Mapt and Grn mutations","volume":"1281","author":"Boeve","year":"2021","journal-title":"Adv Exp Med Biol."},{"key":"B159","first-page":"207","article-title":"\u201cPure Akinesia\u201d and the later added supranuclear ophthalmoplegia","volume":"45","author":"Imai","year":"1987","journal-title":"Adv Neurol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/jnnp.54.5.397","article-title":"Pure Akinesia: An Atypical Manifestation Of Progressive Supranuclear Palsy","volume":"54","author":"Matsuo","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B161","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/mds.21698","article-title":"Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy","volume":"22","author":"Williams","year":"2007","journal-title":"Mov Disord."},{"key":"B162","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/brain\/awm301","article-title":"Clinical and neuropathologic features of progressive supranuclear palsy with severe Pallido-Nigro-Luysial degeneration and axonal dystrophy","volume":"131","author":"Ahmed","year":"2008","journal-title":"Brain."},{"key":"B163","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s00415-016-8278-x","article-title":"The Clinical spectrum and natural history of pure akinesia with gait freezing","volume":"263","author":"Owens","year":"2016","journal-title":"J Neurol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"72","DOI":"10.14802\/jmd.17067","article-title":"Prospective characterization of cognitive function in typical and 'brainstem predominant'progressive supranuclear palsy Phenotypes","volume":"11","author":"Lee","year":"2018","journal-title":"J Mov Disord."},{"key":"B165","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40734-017-0063-1","article-title":"Pure akinesia with gait freezing: a clinicopathologic study","volume":"4","author":"Elkouzi","year":"2017","journal-title":"J Clin Mov Disord."},{"key":"B166","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jns.2004.11.008","article-title":"From Trepidant abasia to motor network failure\u2013gait disorders as a consequence of subcortical vascular encephalopathy (Sve): review of historical and contemporary concepts","volume":"30","author":"Baezner","year":"2005","journal-title":"J Neurol Sci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/mds.23124","article-title":"Primary progressive freezing gait in a patient with co-induced parkinsonism","volume":"25","author":"Lee","year":"2010","journal-title":"Mov Disord."},{"key":"B168","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1212\/01.wnl.0000196469.52995.ab","article-title":"Primary progressive freezing gait: a syndrome with many causes","volume":"66","author":"Factor","year":"2006","journal-title":"Neurology."},{"key":"B169","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mds.22977","article-title":"What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (Psp-P)?","volume":"25","author":"Williams","year":"2010","journal-title":"Mov Disord."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00415-014-7384-x","article-title":"Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study","volume":"261","author":"Jecmenica-Lukic","year":"2014","journal-title":"J Neurol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.parkreldis.2019.07.010","article-title":"Progression of two progressive supranuclear palsy phenotypes with comparable initial disability","volume":"66","author":"Shoeibi","year":"2019","journal-title":"Parkinsonism Relat Disord."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00702-010-0563-8","article-title":"In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism","volume":"118","author":"Srulijes","year":"2011","journal-title":"J Neural Transm."},{"key":"B173","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/mdc3.13396","article-title":"Depression and apathy across different variants of progressive supranuclear palsy","volume":"9","author":"Bower","year":"2022","journal-title":"Mov Disord Clin Pract."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/mdc3.13339","article-title":"Co-occurrence of apathy and impulsivity in progressive supranuclear palsy","volume":"8","author":"Kok","year":"2021","journal-title":"Mov Disord Clin Pract."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/mds.22583","article-title":"Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study","volume":"24","author":"Kanazawa","year":"2009","journal-title":"Mov Disord."},{"key":"B176","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.parkreldis.2011.11.011","article-title":"Serial Mri study in a patient with progressive supranuclear palsy with cerebellar ataxia","volume":"18","author":"Kanazawa","year":"2012","journal-title":"Parkinsonism Relat Disord."},{"key":"B177","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/neup.12012","article-title":"An Autopsied Case of Progressive Supranuclear Palsy Presenting with Cerebellar Ataxia and Severe Cerebellar Involvement","volume":"33","author":"Iwasaki","year":"2013","journal-title":"Neuropathology."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.parkreldis.2013.07.019","article-title":"Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia","volume":"19","author":"Kanazawa","year":"2013","journal-title":"Parkinsonism Relat Disord."},{"key":"B179","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When Dlb, Pd, and Psp Masquerade as Msa: an autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology."},{"key":"B180","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/mds.26499","article-title":"Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of Psp-C","volume":"31","author":"Koga","year":"2016","journal-title":"Mov Disord."},{"key":"B181","doi-asserted-by":"publisher","first-page":"20","DOI":"10.14802\/jmd.19061","article-title":"Progressive supranuclear palsy with predominant cerebellar ataxia","volume":"13","author":"Ando","year":"2020","journal-title":"J Mov Disord."},{"key":"B182","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jns.2012.09.005","article-title":"Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia","volume":"323","author":"Nagao","year":"2012","journal-title":"J Neurol Sci."},{"key":"B183","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2013.03.015","article-title":"Atypical progressive supranuclear palsy presenting as primary lateral sclerosis","volume":"329","author":"King","year":"2013","journal-title":"J Neurol Sci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.jnen.0000218446.38158.61","article-title":"Atypical progressive supranuclear palsy with corticospinal tract degeneration","volume":"65","author":"Josephs","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00401-011-0857-4","article-title":"Globular Glial Tauopathies (Ggt) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies","volume":"122","author":"Ahmed","year":"2011","journal-title":"Acta Neuropathol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamaneurol.2015.2711","article-title":"Globular glial tauopathy presenting as semantic variant primary progressive aphasia","volume":"73","author":"Graff-Radford","year":"2016","journal-title":"JAMA Neurol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s11910-014-0466-4","article-title":"Pathology in primary progressive aphasia syndromes","volume":"14","author":"Harris","year":"2014","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B188","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ana.25333","article-title":"Prevalence of amyloid-beta pathology in distinct variants of primary progressive aphasia","volume":"84","author":"Bergeron","year":"2018","journal-title":"Ann Neurol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.92","article-title":"Patterns of temporal lobe atrophy in semantic dementia and alzheimer's disease","volume":"49","author":"Chan","year":"2001","journal-title":"Ann Neurol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1212\/01.wnl.0000287073.12737.35","article-title":"Progressive aphasia secondary to alzheimer disease Vs Ftld pathology","volume":"70","author":"Josephs","year":"2008","journal-title":"Neurology."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1212\/01.wnl.0000320506.79811.da","article-title":"The logopenic\/phonological variant of primary progressive aphasia","volume":"71","author":"Gorno-Tempini","year":"2008","journal-title":"Neurology."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1212\/WNL.0000000000004034","article-title":"Clinical marker for alzheimer disease pathology in logopenic primary progressive aphasia","volume":"88","author":"Giannini","year":"2017","journal-title":"Neurology."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00019442-200512000-00008","article-title":"Clinical features of argyrophilic grain disease: a retrospective survey of cases with neuropsychiatric symptoms","volume":"13","author":"Togo","year":"2005","journal-title":"Am J Geriatr Psychiatry."},{"key":"B194","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00406-013-0472-6","article-title":"Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders","volume":"264","author":"Nagao","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B195","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/01.jnen.0000225312.11858.57","article-title":"Argyrophilic grain disease in demented subjects presenting initially with amnestic mild cognitive impairment","volume":"65","author":"Jicha","year":"2006","journal-title":"J Neuropathol Exp Neurol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1750-3639.1998.tb00161.x","article-title":"Dementia with grains (Argyrophilic Grain Disease)","volume":"8","author":"Jellinger","year":"1998","journal-title":"Brain Pathol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/13554794.2021.1936072","article-title":"Clinical, neuroimaging, and neuropathological characterization of a patient with alzheimer's disease syndrome due to Pick's pathology","volume":"28","author":"Toller","year":"2021","journal-title":"Neurocase."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0000000000003770","article-title":"Differentiating cognitive impairment due to corticobasal degeneration and alzheimer disease","volume":"88","author":"Day","year":"2017","journal-title":"Neurology."},{"key":"B199","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/WAD.0b013e318298e531","article-title":"Case of globular glial tauopathy presenting clinically as alzheimer disease","volume":"29","author":"SantaCruz","year":"2015","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"B200","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jnen\/nlz017","article-title":"Chronic Traumatic Encephalopathy (Cte) is absent from a European community-based aging cohort while cortical Aging-Related Tau Astrogliopathy (Artag) is highly prevalent","volume":"78","author":"Forrest","year":"2019","journal-title":"J Neuropathol Exp Neurol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00401-007-0266-x","article-title":"Argyrophilic thorny astrocyte clusters in association with alzheimer's disease pathology in possible primary progressive aphasia","volume":"114","author":"Munoz","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B202","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","article-title":"Non-alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series","volume":"126","author":"Kovacs","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.parkreldis.2011.02.017","article-title":"Neuropathological findings of Psp in the elderly without clinical Psp: possible incidental Psp?","volume":"17","author":"Evidente","year":"2011","journal-title":"Parkinsonism Relat Disord."},{"key":"B204","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/NEN.0000000000000046","article-title":"Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers","volume":"73","author":"Dugger","year":"2014","journal-title":"J Neuropathol Exp Neurol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1272\/jnms.82.266","article-title":"Early stage of progressive supranuclear palsy: a neuropathological study of 324 consecutive autopsy cases","volume":"82","author":"Nogami","year":"2015","journal-title":"J Nippon Med Sch."},{"key":"B206","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/nan.12229","article-title":"Pathological features of preclinical or early clinical stages of corticobasal degeneration: a comparison with advanced cases","volume":"41","author":"Nishida","year":"2015","journal-title":"Neuropathol Appl Neurobiol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"Nia-Aa research framework: toward a biological definition of alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B208","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of alzheimer's disease: recommendations of the international working group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3174\/ajnr.A5048","article-title":"A fully automated, atlas-based approach for superior cerebellar peduncle evaluation in progressive supranuclear palsy phenotypes","volume":"38","author":"Nicoletti","year":"2017","journal-title":"AJNR Am J Neuroradiol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.parkreldis.2018.07.016","article-title":"A new Mr imaging index for differentiation of progressive supranuclear palsy-parkinsonism from parkinson's disease","volume":"54","author":"Quattrone","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B211","doi-asserted-by":"publisher","first-page":"101722","DOI":"10.1016\/j.nicl.2019.101722","article-title":"Atrophy in midbrain & cerebral\/cerebellar pedunculi is characteristic for progressive supranuclear palsy - a double-validation whole-brain meta-analysis","volume":"22","author":"Albrecht","year":"2019","journal-title":"Neuroimage Clin."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/ene.12212","article-title":"Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology","volume":"20","author":"Whitwell","year":"2013","journal-title":"Eur J Neurol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1212\/WNL.0000000000003125","article-title":"Mr parkinsonism index predicts vertical supranuclear gaze palsy in patients with Psp-Parkinsonism","volume":"87","author":"Quattrone","year":"2016","journal-title":"Neurology."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1212\/WNL.0b013e31822e55d0","article-title":"Mri Measurements predict Psp in unclassifiable parkinsonisms: a cohort study","volume":"77","author":"Morelli","year":"2011","journal-title":"Neurology."},{"key":"B215","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/mds.28901","article-title":"Brainstem biomarkers of clinical variant and pathology in progressive supranuclear palsy","volume":"37","author":"Grijalva","year":"2021","journal-title":"Mov Disord."},{"key":"B216","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1468-1331.1995.tb00172.x","article-title":"Mri in Corticobasal Degeneration","volume":"2","author":"Grisoli","year":"1995","journal-title":"Eur J Neurol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1212\/WNL.53.3.502","article-title":"Cognitive and Magnetic Resonance Imaging Aspects of Corticobasal Degeneration and Progressive Supranuclear Palsy","volume":"53","author":"Soliveri","year":"1999","journal-title":"Neurology."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1001\/archneur.61.12.1881","article-title":"Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration","volume":"61","author":"Josephs","year":"2004","journal-title":"Arch Neurol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/mds.21055","article-title":"Alzheimer's disease presenting as corticobasal syndrome","volume":"21","author":"Chand","year":"2006","journal-title":"Mov Disord."},{"key":"B220","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.63.1.81","article-title":"Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy","volume":"63","author":"Boxer","year":"2006","journal-title":"Arch Neurol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2006.09.019","article-title":"Voxel-based morphometry in autopsy proven Psp and Cbd","volume":"29","author":"Josephs","year":"2008","journal-title":"Neurobiol Aging."},{"key":"B222","doi-asserted-by":"publisher","first-page":"e00329","DOI":"10.1002\/brb3.329","article-title":"Patterns of gray matter atrophy in atypical parkinsonism syndromes: a Vbm meta-analysis","volume":"5","author":"Yu","year":"2015","journal-title":"Brain Behav."},{"key":"B223","article-title":"Brain volume patterns in corticobasal syndrome vs. idiopathic parkinson's disease","volume-title":"J Neuroimaging.","author":"Ferrea","year":"2022"},{"key":"B224","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1212\/WNL.0b013e3181feb2e8","article-title":"Imaging correlates of pathology in corticobasal syndrome","volume":"75","author":"Whitwell","year":"2010","journal-title":"Neurology."},{"key":"B225","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/brain\/awx293","article-title":"Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia","volume":"141","author":"Tetzloff","year":"2018","journal-title":"Brain."},{"key":"B226","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12031-011-9533-3","article-title":"Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia","volume":"45","author":"Whitwell","year":"2011","journal-title":"J Mol Neurosci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1080\/13554794.2011.627345","article-title":"Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia","volume":"18","author":"Hassan","year":"2012","journal-title":"Neurocase."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/brain\/awaa097","article-title":"Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes","volume":"143","author":"Murley","year":"2020","journal-title":"Brain."},{"key":"B229","unstructured":"FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer's Disease: Food and Drug Administration2020"},{"key":"B230","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18f]flortaucipir and postmortem assessment of alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-Av-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marquie","year":"2015","journal-title":"Ann Neurol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/brain\/aww340","article-title":"18f-Av-1451 positron emission tomography in alzheimer's disease and progressive supranuclear palsy","volume":"140","author":"Passamonti","year":"2017","journal-title":"Brain."},{"key":"B233","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.25060","article-title":"F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and parkinson disease: a multicenter study","volume":"82","author":"Schonhaut","year":"2017","journal-title":"Ann Neurol."},{"key":"B234","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/WNL.0000000000004264","article-title":"In vivo retention of F-Av-1451 in corticobasal syndrome","volume":"89","author":"Smith","year":"2017","journal-title":"Neurology."},{"key":"B235","article-title":"Relationship between F-flortaucipir uptake and histologic lesion types in 4-repeat tauopathies","volume-title":"J Nucl Med.","author":"Josephs","year":"2021"},{"key":"B236","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/awaa383","article-title":"18f-Av-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome","volume":"144","author":"Goodheart","year":"2021","journal-title":"Brain."},{"key":"B237","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.cclet.2022.03.024","article-title":"Recent development in selective tau tracers for pet imaging in the brain","volume":"33","author":"Li","year":"2022","journal-title":"Chin Chem Lett"},{"key":"B238","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/mds.27643","article-title":"In vivo binding of a tau imaging probe, [ C]Pbb3, in patients with progressive supranuclear palsy","volume":"34","author":"Endo","year":"2019","journal-title":"Mov Disord."},{"key":"B239","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/RLU.0000000000002949","article-title":"Tau imaging in the 4-repeat-tauopathies progressive supranuclear palsy and corticobasal syndrome: a 11c-pyridinyl-butadienyl-benzothiazole 3 pet pilot study","volume":"45","author":"Schroter","year":"2020","journal-title":"Clin Nucl Med."},{"key":"B240","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.27013","article-title":"Fluorescence and autoradiographic evaluation of tau pet ligand Pbb3 to Alpha-Synuclein Pathology","volume":"32","author":"Koga","year":"2017","journal-title":"Mov Disord."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/mds.27029","article-title":"Pbb3 imaging in parkinsonian disorders: evidence for binding to tau and other proteins","volume":"32","author":"Perez-Soriano","year":"2017","journal-title":"Mov Disord."},{"key":"B242","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.28672","article-title":"Clinical Utility of F-Apn-1607 Tau Pet imaging in patients with progressive supranuclear palsy","volume":"36","author":"Li","year":"2021","journal-title":"Mov Disord."},{"key":"B243","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [F]Pi-2620, a next-generation tau pet tracer for the assessment of tau pathology in alzheimer's disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B244","doi-asserted-by":"publisher","first-page":"fcab190","DOI":"10.1093\/braincomms\/fcab190","article-title":"Evaluation of [F]Pi-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies","volume":"3","author":"Tezuka","year":"2021","journal-title":"Brain Commun."},{"key":"B245","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18f-Pi-2620 as a biomarker in progressive supranuclear palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1007\/s00259-021-05391-3","article-title":"Feasibility of short imaging protocols for [F]Pi-2620 Tau-Pet in progressive supranuclear palsy","volume":"48","author":"Song","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B247","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/mds.28624","article-title":"Cortical [ F]Pi-2620 Binding differentiates corticobasal syndrome subtypes","volume":"36","author":"Palleis","year":"2021","journal-title":"Mov Disord."},{"key":"B248","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1021\/acschemneuro.0c00801","article-title":"Radiosynthesis, in vitro and in vivo evaluation of [f]cbd-2115 as a first-in-Class Radiotracer for Imaging 4r-tauopathies","volume":"12","author":"Lindberg","year":"2021","journal-title":"ACS Chem Neurosci."},{"key":"B249","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J Neurochem."},{"key":"B250","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jnnp-2014-308004","article-title":"Divergent Csf tau alterations in two common tauopathies: alzheimer's disease and progressive supranuclear palsy","volume":"86","author":"Wagshal","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B251","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1001\/jamaneurol.2018.0118","article-title":"A 2-step cerebrospinal algorithm for the selection of frontotemporal lobar degeneration subtypes","volume":"75","author":"Lleo","year":"2018","journal-title":"JAMA Neurol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"e1137","DOI":"10.1212\/WNL.0000000000200040","article-title":"Cerebrospinal fluid biomarkers in autopsy-confirmed alzheimer disease and frontotemporal lobar degeneration","volume":"98","author":"Mattsson-Carlgren","year":"2022","journal-title":"Neurology."},{"key":"B253","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3233\/JAD-180409","article-title":"Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: a single-center study","volume":"66","author":"Abu-Rumeileh","year":"2018","journal-title":"J Alzheimers Dis."},{"key":"B254","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat Med."},{"key":"B255","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"B256","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.23341","article-title":"Cerebrospinal Fluid Tau And Phosphorylated Tau Protein Are Elevated In Corticobasal Syndrome","volume":"26","author":"Aerts","year":"2011","journal-title":"Mov Disord."},{"key":"B257","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch Neurol."},{"key":"B258","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/13543784.2018.1460356","article-title":"Preclinical, Phase I, and Phase Ii investigational clinical trials for treatment of progressive supranuclear palsy","volume":"27","author":"Shoeibi","year":"2018","journal-title":"Expert Opin Investig Drugs."},{"key":"B259","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00401-018-1948-2","article-title":"Novel Tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in alzheimer's disease","volume":"137","author":"Cicognola","year":"2019","journal-title":"Acta Neuropathol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/acn3.290","article-title":"Plasma neurofilament light chain predicts progression in progressive supranuclear palsy","volume":"3","author":"Rojas","year":"2016","journal-title":"Ann Clin Transl Neurol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.parkreldis.2018.06.018","article-title":"Serum neurofilament light chain in progressive supranuclear palsy","volume":"56","author":"Donker Kaat","year":"2018","journal-title":"Parkinsonism Relat Disord."},{"key":"B262","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1212\/WNL.0000000000004859","article-title":"Csf Neurofilament light chain and phosphorylated tau 181 predict disease progression in Psp","volume":"90","author":"Rojas","year":"2018","journal-title":"Neurology."},{"key":"B263","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in parkinson's disease and atypical parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism Relat Disord."},{"key":"B264","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-Based Nfl: a biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/mds.28543","article-title":"Cerebrospinal fluid proteins altered in corticobasal degeneration","volume":"36","author":"Paslawski","year":"2021","journal-title":"Mov Disord."},{"key":"B266","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/medicina58040483","article-title":"Microrna as candidate biomarkers in atypical parkinsonian syndromes: systematic literature review","volume":"58","author":"Bougea","year":"2022","journal-title":"Medicina."},{"key":"B267","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-020-0887-z","article-title":"A single ultrasensitive assay for detection and discrimination of tau aggregates of alzheimer and pick diseases","volume":"8","author":"Metrick","year":"2020","journal-title":"Acta Neuropathol Commun."},{"key":"B268","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-019-02080-2","article-title":"4-repeat tau seeds and templating subtypes as brain and Csf biomarkers of frontotemporal lobar degeneration Acta Neuropathol","volume":"139","author":"Saijo","year":"2020"}],"updated-by":[{"DOI":"10.3389\/fneur.2022.1015572","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000}}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.944806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T11:34:19Z","timestamp":1663068859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.944806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":268,"alternative-id":["10.3389\/fneur.2022.944806"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.944806","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"944806"}}